1. Home
  2. CADL vs NUS Comparison

CADL vs NUS Comparison

Compare CADL & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
    SELLHOLDBUYas of 20 hours ago
  • NUS
    SELLHOLDBUYas of 20 hours ago
  • Stock Information
  • Founded
  • CADL 1999
  • NUS 1984
  • Country
  • CADL United States
  • NUS United States
  • Employees
  • CADL N/A
  • NUS N/A
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • NUS Other Pharmaceuticals
  • Sector
  • CADL Health Care
  • NUS Health Care
  • Exchange
  • CADL Nasdaq
  • NUS Nasdaq
  • Market Cap
  • CADL 306.4M
  • NUS 321.6M
  • IPO Year
  • CADL 2021
  • NUS 1996
  • Fundamental
  • Price
  • CADL $7.81
  • NUS $6.93
  • Analyst Decision
  • CADL Strong Buy
  • NUS Hold
  • Analyst Count
  • CADL 4
  • NUS 2
  • Target Price
  • CADL $21.00
  • NUS $6.88
  • AVG Volume (30 Days)
  • CADL 890.2K
  • NUS 676.2K
  • Earning Date
  • CADL 03-13-2025
  • NUS 05-07-2025
  • Dividend Yield
  • CADL N/A
  • NUS 3.43%
  • EPS Growth
  • CADL N/A
  • NUS N/A
  • EPS
  • CADL N/A
  • NUS N/A
  • Revenue
  • CADL N/A
  • NUS $1,732,084,000.00
  • Revenue This Year
  • CADL N/A
  • NUS N/A
  • Revenue Next Year
  • CADL N/A
  • NUS N/A
  • P/E Ratio
  • CADL N/A
  • NUS N/A
  • Revenue Growth
  • CADL N/A
  • NUS N/A
  • 52 Week Low
  • CADL $1.45
  • NUS $5.95
  • 52 Week High
  • CADL $14.60
  • NUS $14.04
  • Technical
  • Relative Strength Index (RSI)
  • CADL 46.96
  • NUS 38.12
  • Support Level
  • CADL $8.03
  • NUS $6.79
  • Resistance Level
  • CADL $8.69
  • NUS $8.35
  • Average True Range (ATR)
  • CADL 0.54
  • NUS 0.32
  • MACD
  • CADL -0.04
  • NUS -0.17
  • Stochastic Oscillator
  • CADL 34.97
  • NUS 8.81

Stock Price Comparison Chart: CADL vs NUS

CADL
NUS
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202505101520253035404550556065CADL VS NUS

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use